SEC Form 4 research

EyePoint Pharmaceuticals, Inc. insider transactions

IssuerEyePoint Pharmaceuticals, Inc.
TickersEYPT, PSDV, EYEP
Reporting owners46
Officers and directors18
Last public filing2026-08-19

Recent insider disclosures

AvailableTrade dateReporting ownersCodeSharesPriceReported value
2026-08-182026-08-18Zaderej Karen L.P10,600$4.93Not reported

Officers and directors in the directory

Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.

NexusTrade Loading NexusTrade… Taking too long? Reload this page